A fall on the head, a blow to the skull, or a road traffic accident—the causes of traumatic brain injury are diverse, but the ...
Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair strategy, new research suggests. Capitalizing on the flexibility of tiny ...
A newly discovered mechanism that protects nerve cells could have important implications for understanding and treating ...
Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury. Since the passing of ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for serious neurological ...
A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial. It's a ...
This illustration outlines the comprehensive research strategy combining computational biology, machine learning, and experimental validation. Using network toxicology, 238 overlapping targets were ...
Imaging shows regeneration of sensory axons four weeks after a spinal cord injury in an adult mouse injected with PDGF-BB at the lesion site. COLUMBUS, Ohio – Capitalizing on the flexibility of tiny ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results